226 related articles for article (PubMed ID: 32309384)
1. Circulating tumor DNA correlates with microvascular invasion and predicts tumor recurrence of hepatocellular carcinoma.
Wang J; Huang A; Wang YP; Yin Y; Fu PY; Zhang X; Zhou J
Ann Transl Med; 2020 Mar; 8(5):237. PubMed ID: 32309384
[TBL] [Abstract][Full Text] [Related]
2. Detecting Circulating Tumor DNA in Hepatocellular Carcinoma Patients Using Droplet Digital PCR Is Feasible and Reflects Intratumoral Heterogeneity.
Huang A; Zhang X; Zhou SL; Cao Y; Huang XW; Fan J; Yang XR; Zhou J
J Cancer; 2016; 7(13):1907-1914. PubMed ID: 27698932
[TBL] [Abstract][Full Text] [Related]
3. Preoperative evaluation of microvascular invasion with circulating tumour DNA in operable hepatocellular carcinoma.
Wang D; Xu Y; Goldstein JB; Ye K; Hu X; Xiao L; Li L; Chang L; Guan Y; Long G; He Q; Yi X; Zhang J; Wang Z; Xia X; Zhou L
Liver Int; 2020 Aug; 40(8):1997-2007. PubMed ID: 32279416
[TBL] [Abstract][Full Text] [Related]
4. Assessments of TP53 and CTNNB1 gene hotspot mutations in circulating tumour DNA of hepatitis B virus-induced hepatocellular carcinoma.
Kumar S; Nadda N; Quadri A; Kumar R; Paul S; Tanwar P; Gamanagatti S; Dash NR; Saraya A; Shalimar ; Nayak B
Front Genet; 2023; 14():1235260. PubMed ID: 37593116
[No Abstract] [Full Text] [Related]
5. Cancer Genomic Alterations Can Be Potential Biomarkers Predicting Microvascular Invasion and Early Recurrence of Hepatocellular Carcinoma.
Xin Z; Li J; Zhang H; Zhou Y; Song J; Chen P; Bai L; Chen H; Zhou J; Chen J; Ying B
Front Oncol; 2022; 12():783109. PubMed ID: 35155229
[TBL] [Abstract][Full Text] [Related]
6. TP53 mutation detected in circulating exosomal DNA is associated with prognosis of patients with hepatocellular carcinoma.
Li Y; Wu J; Li E; Xiao Z; Lei J; Zhou F; Yin X; Hu D; Mao Y; Wu L; Wenjun L
Cancer Biol Ther; 2022 Dec; 23(1):439-445. PubMed ID: 35921289
[TBL] [Abstract][Full Text] [Related]
7. Preoperative circulating tumor cells to predict microvascular invasion and dynamical detection indicate the prognosis of hepatocellular carcinoma.
Zhou J; Zhang Z; Zhou H; Leng C; Hou B; Zhou C; Hu X; Wang J; Chen X
BMC Cancer; 2020 Oct; 20(1):1047. PubMed ID: 33129301
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of postoperative adjuvant transcatheter arterial chemoembolization in hepatocellular carcinoma patients with microvascular invasion.
Ye JZ; Chen JZ; Li ZH; Bai T; Chen J; Zhu SL; Li LQ; Wu FX
World J Gastroenterol; 2017 Nov; 23(41):7415-7424. PubMed ID: 29151695
[TBL] [Abstract][Full Text] [Related]
9. The prognostic value of microvascular invasion in early-intermediate stage hepatocelluar carcinoma: a propensity score matching analysis.
Shen J; Wen J; Li C; Wen T; Yan L; Li B; Yang J; Lu C
BMC Cancer; 2018 Mar; 18(1):278. PubMed ID: 29530006
[TBL] [Abstract][Full Text] [Related]
10. Detection of oncogenic mutations in paired circulating tumor DNA and circulating tumor cells in patients with hepatocellular carcinoma.
Ge Z; Helmijr JCA; Jansen MPHM; Boor PPC; Noordam L; Peppelenbosch M; Kwekkeboom J; Kraan J; Sprengers D
Transl Oncol; 2021 Jul; 14(7):101073. PubMed ID: 33915518
[TBL] [Abstract][Full Text] [Related]
11. Whole-exome sequencing reveals the metastatic potential of hepatocellular carcinoma from the perspective of tumor and circulating tumor DNA.
Zhou C; Weng J; Liu S; Zhou Q; Hu Z; Yin Y; Lv P; Sun J; Li H; Yi Y; Shen Y; Ye Q; Shi Y; Dong Q; Liu C; Zhu X; Ren N
Hepatol Int; 2023 Dec; 17(6):1461-1476. PubMed ID: 37217808
[TBL] [Abstract][Full Text] [Related]
12. Association of Preoperative Antiviral Treatment With Incidences of Microvascular Invasion and Early Tumor Recurrence in Hepatitis B Virus-Related Hepatocellular Carcinoma.
Li Z; Lei Z; Xia Y; Li J; Wang K; Zhang H; Wan X; Yang T; Zhou W; Wu M; Pawlik TM; Lau WY; Shen F
JAMA Surg; 2018 Oct; 153(10):e182721. PubMed ID: 30073257
[TBL] [Abstract][Full Text] [Related]
13. The diagnostic and prognostic usage of circulating tumor DNA in operable hepatocellular carcinoma.
An Y; Guan Y; Xu Y; Han Y; Wu C; Bao C; Zhou B; Wang H; Zhang M; Liu W; Qiu L; Han Z; Chen Y; Xia X; Wang J; Liu Z; Huang W; Yi X; Huang J
Am J Transl Res; 2019; 11(10):6462-6474. PubMed ID: 31737198
[TBL] [Abstract][Full Text] [Related]
14. Predictive value of gamma-glutamyl transpeptidase to lymphocyte count ratio in hepatocellular carcinoma patients with microvascular invasion.
Zhang H; Zhou Y; Li Y; Qin W; Zi Y; Liu Y; Qiu X; Xu H; Liao W; Huang Z
BMC Cancer; 2020 Feb; 20(1):132. PubMed ID: 32070301
[TBL] [Abstract][Full Text] [Related]
15. Preoperative serum ctDNA predicts early hepatocellular carcinoma recurrence and response to systemic therapies.
Fu Y; Yang Z; Hu Z; Yang Z; Pan Y; Chen J; Wang J; Hu D; Zhou Z; Xu L; Chen M; Zhang Y
Hepatol Int; 2022 Aug; 16(4):868-878. PubMed ID: 35674872
[TBL] [Abstract][Full Text] [Related]
16. Postoperative adjuvant transarterial chemoembolization for multinodular hepatocellular carcinoma within the Barcelona Clinic Liver Cancer early stage and microvascular invasion.
Wang H; Du PC; Wu MC; Cong WM
Hepatobiliary Surg Nutr; 2018 Dec; 7(6):418-428. PubMed ID: 30652086
[TBL] [Abstract][Full Text] [Related]
17. Impact of preoperative TACE on incidences of microvascular invasion and long-term post-hepatectomy survival in hepatocellular carcinoma patients: A propensity score matching analysis.
Yang Y; Lin K; Liu L; Qian Y; Yang Y; Yuan S; Zhu P; Huang J; Liu F; Gu F; Fu S; Jiang B; Liu H; Pan Z; Lau WY; Zhou W
Cancer Med; 2021 Mar; 10(6):2100-2111. PubMed ID: 33650288
[TBL] [Abstract][Full Text] [Related]
18. A clinical prognostic model for patients with esophageal squamous cell carcinoma based on circulating tumor DNA mutation features.
Liu T; Li M; Cheng W; Yao Q; Xue Y; Wang X; Jin H
Front Oncol; 2022; 12():1025284. PubMed ID: 36686833
[TBL] [Abstract][Full Text] [Related]
19. The prognostic significance of inflammation-immunity-nutrition score on postoperative survival and recurrence in hepatocellular carcinoma patients.
Liang Y; Zhang Z; Zhong D; Lai C; Dai Z; Zou H; Feng T; Shang J; Shi Y; Huang X
Front Oncol; 2022; 12():913731. PubMed ID: 36016629
[TBL] [Abstract][Full Text] [Related]
20. A Novel Inflammation-Based Prognostic Score: The Fibrinogen/Albumin Ratio Predicts Prognoses of Patients after Curative Resection for Hepatocellular Carcinoma.
Xu Q; Yan Y; Gu S; Mao K; Zhang J; Huang P; Zhou Z; Chen Z; Zheng S; Liang J; Lin Z; Wang J; Yan J; Xiao Z
J Immunol Res; 2018; 2018():4925498. PubMed ID: 30027102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
